It was previously demonstrated that EPA and docosahexaenoic acid (22:6n-3, DHA) decrease the proliferation and increase the apoptosis of human breast cancer cells by inhibition of signaling through the Akt/NFκB cell survival pathway [81]. This evidence concerns the gene NFKB1 and breast carcinoma.